会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • POLYALKOXYLATED ALCOHOLS AS EXCIPIENTS FOR PHARMACEUTICAL COMPOSITIONS
    • 聚烷氧基醇作为药物组合物的成分
    • WO2014149160A1
    • 2014-09-25
    • PCT/US2014/011284
    • 2014-01-13
    • DOW GLOBAL TECHNOLOGIES LLC
    • LADIKA, MladenZHAO, JinTULCHINSKY, Michael L.KALANTAR, Thomas H.HARRIS, J. Keith
    • A61K47/10A61K9/48A61K31/10A61K31/192A61K31/58A61K31/70C08G65/20
    • A61K47/10A61K9/4866A61K31/095A61K31/10A61K31/192A61K31/343A61K31/58C08G65/20C08L71/02
    • The present invention relates to the use of polyalkoxylated alcohols of the formula R-O-(AO)-H, wherein R is a substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl, aralkyl or heterocyclic group having 7 to 25 carbon atoms, (AO) is a polyoxyalkylene moiety of the composition (BO)m(EO)n(DO)r with random or blockwise arrangement of the constituting oxyalkylene units, wherein m, n and r represent the average number of oxybutylene (BO) units, oxyethylene (EO) units and oxyalkylene units derived from at least one epoxide selected from styrene oxide and alkylene oxides having from 5 to 10 carbon atoms (DO) per molecule of the polyalkoxylated alcohol, respectively, m being a number greater than or equal to 1, n being a number greater than or equal to 1 and r being a number in the range from 0 to 50 under the proviso that (m+n+r) is less than or equal to 200 and the ratio n/(m+r) is in the range of 1 to 20, as excipients in pharmaceutical compositions. Said polyalkoxylated alcohols enable very effective solubilisation of poorly soluble active pharmaceutical ingredients in aqueous media. Solid or semi-solid pharmaceutical compositions comprising one or more such polyalkoxylated alcohol combined with at least one active pharmaceutical ingredient are further long term stable under typical storage conditions and can be readily provided in various dosage forms such as tablets and filled capsules.
    • 本发明涉及式RO-(AO)-H的聚烷氧基化醇的用途,其中R是具有7至25个碳原子的取代或未取代的烷基,烯基,炔基,芳基,芳烷基或杂环基,(AO) 是组成(BO)m(EO)n(DO)r的聚氧化烯部分,其中构成氧化烯单元具有随机或间隔排列,其中m,n和r表示氧联苯(BO)单元的平均数,氧化乙烯(EO )单元和衍生自至少一种选自氧化苯乙烯和每分子聚烷氧基化醇具有5至10个碳原子的氧化烯(DO)的环氧化物)的氧化烯单元,m分别为大于或等于1的数,n为 大于或等于1的数,r为0至50的数,条件是(m + n + r)小于或等于200,并且比率n /(m + r)在 范围为1至20,作为药物组合物中的赋形剂。 所述聚烷氧基化的醇使得难溶性活性药物成分在水性介质中非常有效地溶解。 包含一种或多种这样的多烷氧基化醇与至少一种活性药物成分组合的固体或半固体药物组合物在典型的储存条件下进一步长期稳定,并且可以容易地以各种剂型例如片剂和填充的胶囊提供。